Vaccines, blood, antisera, toxins and cultures in   Senegal

Exports In 2022, Senegal exported $386k in Vaccines, blood, antisera, toxins and cultures, making it the 113th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 269th most exported product in Senegal. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Senegal are: Burkina Faso ($82.4k), Cameroon ($58.7k), Mauritania ($58.4k), Guinea ($53.9k), and Cote d'Ivoire ($51.3k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Senegal between 2021 and 2022 were Cote d'Ivoire ($44.8k), Cameroon ($39.9k), and Mauritania ($26.9k).

Imports In 2022, Senegal imported $36.5M in Vaccines, blood, antisera, toxins and cultures, becoming the 135th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 96th most imported product in Senegal. Senegal imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($11.3M), United States ($5.39M), India ($5.31M), France ($3.56M), and Denmark ($2.5M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Senegal between 2021 and 2022 were Belgium ($8.48M), Denmark ($1.39M), and Brazil ($1.32M).